Growth and nucleic acid synthesis in normal cells and cells infected with Rous sarcoma virus.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H Rubin.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A method for studying inhibitors of the contact stages of blood coagulation is described. A number of positively charged substances were shown to inhibit the contact stages. The inhibitory substances include spermine, cytochrome c, ribonuclease, and lysozyme. The inhibitory effect of these substances was neutralized by the addition of an activated plasma thromboplastin antecedent, factor XI, (PTA) fraction. Other positively charged substances including protamine, hexadimethrine, polylysine, polyornithine, methylene blue, and ortho-toluidine blue also inhibited the contact stages of coagulation, but the inhibitory effect on coagulation was not neutralized by the activated PTA fraction. Negatively charged substances such as heparin and insulin did not inhibit the contact stages of coagulation. Cytochrome c inhibited Celite adsorption of a partially purified Hageman factor fraction, and cytochrome, ribonuclease, spermine, and lysozome inhibited the adsorption of Hageman factor from PTA-deficient plasma. Very much smaller quantities of Celite completely adsorbed Hageman factor from the fraction rather than from whole plasma, which suggested the possibility that plasma contains an inhibitor or inhibitors of Hageman factor adsorption. Furthermore cytochrome c, spermine, ribonuclease, and lysozyme inhibited the coagulant activity of the following activators of the Hageman and PTA factors: Celite, kaolin, sodium stearate, ellagic acid, and skin. It is suggested that negatively charged sites on these activators are critical for adsorption and activation and that inhibition results from neutralization of the negatively charged sites by the adsorbed inhibtor. Tests with polylysine polymers indicate that inhibitory activity is directly related to molecular size over the molecular weight range of 4000 to 100,000.
Recent studies suggested a general behavioral engineering approach to behavioral disorders by portable operant treatment instruments. The approach was applied to the problem of poor posture, specifically rounding of the back or slouching. An apparatus was developed that provided a warning stimulus followed by an aversive tone for the duration of slouching. Slouching was thereby punished by onset of the tone, and non-slouching was reinforced by tone termination and postponement. Twenty-five adults wore the apparatus during their normal working day during alternate periods in which the aversive tone was connected and disconnected experimentally. A miniature time-meter recorded the duration of slouching. The results showed that slouching decreased for each subject during each period in which slouching produced the aversive tone. For two subjects, a second control procedure was applied in which slouching terminated the tone. The result was an increase of slouching, demonstrating that the postural changes were controlled by the scheduled relation between the aversive tone and the response, and not by other factors such as simple response feedback. The substantial changes in posture indicate that the present procedure may prove to be an effective treatment alternative and suggests the general value of the behavioral engineering approach.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.